Vascular involvement is greater in BMS-COPD; greater arteriolar wall thickening, and intense perivascular inflammatory cell (neutrophil and macrophage) infiltrates with activation of the Jun Kinase pathway result in greater incidence and severity of pulmonary hypertension and cor-pulmonale. The gene discussed is MAPK9; the disease is pulmonary arterial hypertension.